Dld Asset Management, LP Biomarin Pharmaceutical Inc Call Options Transaction History

Dld Asset Management, LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $1.89 Million - $2.12 Million	-25,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $1.87 Million - $2.27 Million	25,000 New	25,000 $1.89 Million
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $2.54 Million - $3.96 Million	-31,900 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $706,563 - $958,815	9,900 Added 45.0%	31,900 $2.7 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $1.03 Million - $1.38 Million	16,000 Added 266.67%	22,000 $1.86 Million
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $303,300 - $382,995	-4,500 Reduced 42.86%	6,000 $404,000
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $843,674 - $985,950	10,500 New	10,500 $900,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.